Jasper Therapeutics, Inc.·4

Nov 20, 8:14 PM ET

WIGGANS THOMAS G 4

4 · Jasper Therapeutics, Inc. · Filed Nov 20, 2023

Insider Transaction Report

Form 4
Period: 2023-11-16
Transactions
  • Purchase

    Voting Common Stock

    2023-11-20$0.63/sh+10,000$6,30930,000 total
  • Purchase

    Voting Common Stock

    2023-11-16$0.60/sh+10,000$5,96510,000 total
  • Purchase

    Voting Common Stock

    2023-11-17$0.60/sh+10,000$5,96620,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary